Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joris Galland

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|March 14, 2020
Impact of Simulation-Based Learning on National Ranking Medical Examination Results in France: A Randomized Trial (SimECNi Study)Joris Galland, Nihal Martis, Michael Levraut, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 6, 2016
Lupus anticoagulant-hypoprothrombinemia syndrome and catastrophic antiphospholipid syndrome in a patient with antidomain I antibodiesJoris Galland, Shirine Mohamed, Sabine Revuz, et al.
Plos One|February 24, 2023
Exploratory study: Evaluation of a symptom checker effectiveness for providing a diagnosis and evaluating the situation emergency compared to emergency physicians using simulated and standardized patientsLaure Abensur Vuillaume, Julien Turpinier, Lauriane Cipolat, et al.
Helicobacter|February 15, 2021
"Helicobacter pylori in familial mediterranean fever: A series of 120 patients from literature and from france"Carole Lacout, Léa Savey, Rim Bourguiba, et al.
International Journal of Clinical Practice|September 7, 2021
AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of "monoclonal gammopathy of inflammatory significance"?Alexandre Terré, Magali Colombat, Alexandre Cez, et al.
Medicine|May 25, 2021
No evidence of tocilizumab treatment efficacy for severe to critical SARS-CoV2 infected patients: Results from a retrospective controlled multicenter studyRuxandra Burlacu, Jonathan London, Audrey Fleury, et al.
Journal of Internal Medicine|September 23, 2025
Characterizing VEXAS syndrome in women: Findings from an international multicenter studyRim Bourguiba, Valentin Lacombe, David Beck, et al.
Autoimmunity Reviews|December 16, 2019
Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature reviewAnne Laure Roupie, Hubert de Boysson, Sara Thietart, et al.
Iscience|February 13, 2023
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variantsCamille Chauvin, Laurine Levillayer, Mathilde Roumier, et al.
RMD Open|July 22, 2022
Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patientsMohamed-Yacine Khitri, Alexis F Guedon, Sophie Georgin-Lavialle, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|March 14, 2020
Impact of Simulation-Based Learning on National Ranking Medical Examination Results in France: A Randomized Trial (SimECNi Study)Joris Galland, Nihal Martis, Michael Levraut, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 6, 2016
Lupus anticoagulant-hypoprothrombinemia syndrome and catastrophic antiphospholipid syndrome in a patient with antidomain I antibodiesJoris Galland, Shirine Mohamed, Sabine Revuz, et al.
Plos One|February 24, 2023
Exploratory study: Evaluation of a symptom checker effectiveness for providing a diagnosis and evaluating the situation emergency compared to emergency physicians using simulated and standardized patientsLaure Abensur Vuillaume, Julien Turpinier, Lauriane Cipolat, et al.
Helicobacter|February 15, 2021
"Helicobacter pylori in familial mediterranean fever: A series of 120 patients from literature and from france"Carole Lacout, Léa Savey, Rim Bourguiba, et al.
International Journal of Clinical Practice|September 7, 2021
AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of "monoclonal gammopathy of inflammatory significance"?Alexandre Terré, Magali Colombat, Alexandre Cez, et al.
Medicine|May 25, 2021
No evidence of tocilizumab treatment efficacy for severe to critical SARS-CoV2 infected patients: Results from a retrospective controlled multicenter studyRuxandra Burlacu, Jonathan London, Audrey Fleury, et al.
Journal of Internal Medicine|September 23, 2025
Characterizing VEXAS syndrome in women: Findings from an international multicenter studyRim Bourguiba, Valentin Lacombe, David Beck, et al.
Autoimmunity Reviews|December 16, 2019
Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature reviewAnne Laure Roupie, Hubert de Boysson, Sara Thietart, et al.
Iscience|February 13, 2023
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variantsCamille Chauvin, Laurine Levillayer, Mathilde Roumier, et al.
RMD Open|July 22, 2022
Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patientsMohamed-Yacine Khitri, Alexis F Guedon, Sophie Georgin-Lavialle, et al.
Pageof 2